Focus on COVID-19 Impact on the Cardiovascular System

The global spread of coronavirus disease 2019 (COVID-19) persists. With over 3 million infections and more than 210,000 deaths to date, the pandemic continues to present significant challenges to health systems around the world, and across all branches of medicine.

In response to the COVID-19 pandemic, the scientific community has united to tackle the disease, with many studies initiated to understand its mechanism and treatment options. Scientific societies have provided guidance for the treatment of patients with comorbidities, and journals have provided open access to scientific literature in an attempt to disseminate knowledge and contribute to better outcomes.

Here, we focus on the implications of the COVID-19 pandemic for cardiovascular medicine. Emerging studies address how COVID-19 impacts the cardiovascular system, the status of prospective treatment approaches, and the importance of safety for healthcare providers on the frontline. The information included acknowledges the significant contribution of researchers, scientific societies and publishers, and does not necessarily reflect a position of Edwards Lifesciences in relation to individual studies.

For professional use.

Edwards Lifesciences, the stylized E logo, are trademarks of Edwards Lifesciences Corporation or its affiliates. All other trademarks or service marks are the property of their respective owners.

© 2020 Edwards Lifesciences Corporation. All rights reserved. PP–EU-0209 v1.0

Edwards Lifesciences• Route de l’Etraz 70, 1260 Nyon, Switzerland • edwards.com